[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351320-105":59,"doc-detail-351320-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multi-omics-analysis-of-cdkn2a-p16ink4a-in-cervical-carcinoma-in-the-context-of-human-papillomavirus-and-in-endometrial-carcinoma","Multi-Omics Analysis of CDKN2A (p16INK4a) in Cervical Carcinoma in the Context of Human Papillomavirus and in Endometrial Carcinoma","","CDKN2A (p16INK4a) regulates the RB–E2F cell-cycle checkpoint and is a known surrogate marker for high-risk HPV-related cervical neoplasia, yet its diagnostic and prognostic role in uterine corpus endometrial carcinoma (UCEC), largely HPV-independent, remains insufficiently defined. Integrated multi-omics analyses evaluated CDKN2A dysregulation in CESC and UCEC, combining differential expression, immunohistochemistry protein profiling, survival and immune-infiltration assessment, and independent GEO validation with diagnostic ROC-AUC performance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omics-analysis-of-cdkn2a-p16ink4a-in-cervical-carcinoma-in-the-context-of-human-papillomavirus-and-in-endometrial-carcinoma/351320/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omics-analysis-of-cdkn2a-p16ink4a-in-cervical-carcinoma-in-the-context-of-human-papillomavirus-and-in-endometrial-carcinoma/351320.png","ImageObject",300,407,{"name":92,"@type":93},"Connor ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is CDKN2A (p16INK4a) and why is it important in this study?","Question",{"text":112,"@type":113},"CDKN2A (p16INK4a) is integral to the RB–E2F cell-cycle checkpoint and is widely used as a surrogate marker for high-risk HPV-related cervical neoplasia. The study investigates whether its diagnostic and prognostic value extends to endometrial carcinoma.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was CDKN2A dysregulation assessed across cancers?",{"text":117,"@type":113},"The study applied integrated multi-omics analyses including pan-cancer and tumor–normal differential expression (TIMER2.0, GEPIA2), protein pattern analysis via immunohistochemistry data (Human Protein Atlas), and prognostic and immune-infiltration evaluation using TCGA survival and TIMER modules. Independent transcriptomic validation used GEO datasets with ROC-AUC and cross-validation.",{"name":119,"@type":110,"acceptedAnswer":120},"What diagnostic performance did CDKN2A show in cervical vs. endometrial carcinoma?",{"text":121,"@type":113},"In independent GEO cohorts, CDKN2A discriminated tumor vs. normal with excellent performance in CESC (AUC = 0.982) and moderate performance in UCEC (AUC = 0.761). The results support strong diagnostic utility in HPV-associated cervical cancer and cohort-dependent discrimination in endometrial carcinoma.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351320,1790167343,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687207022233,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nMulti-Omics Analysis of CDKN2A (p16INK4a) in Cervical Carcinoma in the Context of Human Papillomavirus and in Endometrial Carcinoma  \nRasha Elsayim 1,*, Heba W. Alhamdi 2, Nihal Almuraikhi 3, Mariam Abdulaziz Alkhateeb 4, Taghreed Mohamed Osman Derar 5, Sami Habiballa Abdalla Mohamed 5 and Esra’a Abudouleh 1, *  \nAcademic Editor: Ilya Ioshikhes  \nReceived: 3 February 2026  \nRevised: 24 February 2026  \nAccepted: 25 February 2026  \nPublished: 27 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia  \n2 Department of Biology, College of Sciences, King Khalid University, P.O. Box 960, Abha 61413, Saudi Arabia  \n3 Stem Cell Unit, Department of Anatomy, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia; [nalmuraikhi@ksu.edu.sa](nalmuraikhi@ksu.edu.sa)  \n4 Department of Biology, College of Science, Princess Nourah bint Abdulrahman University,  \nP.O. Box 84428, Riyadh 11671, Saudi Arabia  \n5 Health Sciences Department, College of Applied Studies, King Saud University, Riyadh 12372, Saudi Arabia; [samabdalla@ksu.edu.sa](samabdalla@ksu.edu.sa) (S.H.A.M.)  \n* Correspondence: [relsayim.c@ksu.edu.sa](relsayim.c@ksu.edu.sa) (R.E.); [eabudouleh@ksu.edu.sa](eabudouleh@ksu.edu.sa) (E.A.)  \nAbstract  \nBackground: CDKN2A (p16ˆINK4aˆ) is integral to the regulation of the RB–E2F cell-cycle checkpoint and is widely acknowledged as a surrogate marker for high-risk human papillomavirus (HPV)-related cervical neoplasia. Nevertheless, its diagnostic and prognostic significance in uterine corpus endometrial carcinoma (UCEC), a predominantly HPVindependent malignancy, remains inadequately characterized. This study utilized an integrated multi-omics approach to examine CDKN2A dysregulation in cervical squamous cell carcinoma (CESC) and UCEC. Methods: Pan-cancer and tumor–normal differential expression analyses were performed using TIMER2.0 and GEPIA2 (TCGA/GTEx) . Clinicopathological correlations were assessed with UALCAN. Protein expression patterns were analyzed using immunohistochemistry data from the Human Protein Atlas (HPA) . Prognostic significance and immune-infiltration associations were evaluated using TCGA survival data and TIMER modules. Independent transcriptomic validation and diagnostic classification performance were assessed using GEO datasets GSE9750 (CESC) and GSE63678 (UCEC), including ROC-AUC analysis with cross-validation. Results: Integrated analyses revealed elevated CDKN2A expression in both CESC and UCEC across multiple transcriptomic cohorts, with pronounced tumor-specific protein expression on immunohistochemistry. TCGA-only tumor–normal RNA comparisons were non-significant, likely due to limited normal sample representation. In independent GEO cohorts, CDKN2A exhibited excellent tumor–normal discrimination in CESC (AUC = 0.982) and moderate discrimination in UCEC (AUC = 0.761) . Survival analysis indicated tumor-specific patterns, with limited prognostic stratification in CESC and context-dependent associations in UCEC. Immune-infiltration analysis suggested tumor-type-specific interactions between CDKN2A expression and immune cell subsets. Conclusions: CDKN2A exhibits strong diagnostic performance in HPV-associated cervical cancer and moderate, cohort-dependent discriminatory ability in endometrial carcinoma. These findings reinforce its established diagnostic role in CESC and propose adjunctive utility in UCEC, underscoring the importance of tumor-contextual interpretation of CDKN2A expression in gynecologic malignancies.  \nKeywords: CDKN2A; cervical squamous cell carcinoma; endometrial carcinoma; human papillomavirus; transcriptomic and proteomic evidence  \n1. Introduction  \nCervical squamous cell carcinoma (CESC) and ute","cbCaijbgXHl73DvL","https://ap.wps.com/l/cbCaijbgXHl73DvL","pdf",4465741,21,"English","# Abstract\n## Background, Methods, Results, Conclusions","[{\"question\":\"What is CDKN2A (p16INK4a) and why is it important in this study?\",\"answer\":\"CDKN2A (p16INK4a) is integral to the RB–E2F cell-cycle checkpoint and is widely used as a surrogate marker for high-risk HPV-related cervical neoplasia. The study investigates whether its diagnostic and prognostic value extends to endometrial carcinoma.\"},{\"question\":\"How was CDKN2A dysregulation assessed across cancers?\",\"answer\":\"The study applied integrated multi-omics analyses including pan-cancer and tumor–normal differential expression (TIMER2.0, GEPIA2), protein pattern analysis via immunohistochemistry data (Human Protein Atlas), and prognostic and immune-infiltration evaluation using TCGA survival and TIMER modules. Independent transcriptomic validation used GEO datasets with ROC-AUC and cross-validation.\"},{\"question\":\"What diagnostic performance did CDKN2A show in cervical vs. endometrial carcinoma?\",\"answer\":\"In independent GEO cohorts, CDKN2A discriminated tumor vs. normal with excellent performance in CESC (AUC = 0.982) and moderate performance in UCEC (AUC = 0.761). The results support strong diagnostic utility in HPV-associated cervical cancer and cohort-dependent discrimination in endometrial carcinoma.\"}]","Multi-Omics Analysis of CDKN2A (p16INK4a) in Cervical Carcinoma in the Context of Human Papillomavirus and in Endometrial Carcinoma | PDF",1790093543,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5913440ec1dd4675bb662cb1f448e114.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48e01468d7c4269a2cc69545183ea71b.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d0c25aac69c91011e66598221b8fc08.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9fdf59ac92cf03ca503108d61348651c.webp",980,1385]